Trial Profile
A Study to Evaluate the Efficacy and Safety of Intradetrusor OnabutulinumtoxinA Injections in Patients With Refractory Neurogenic Detrusor Overactivity With and Without Bacteriuria Prior Treatment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Jul 2016
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Overactive bladder
- Focus Adverse reactions; Therapeutic Use
- 07 Jul 2016 New trial record